Article

Repurposing of Miglustat to inhibit the coronavirus Severe Acquired Respiratory Syndrome SARS-CoV-2

2020-05-18

Abstract excerpt

Repurposing clinically available drugs to treat the new coronavirus disease COVID-19 is an urgent need in these early stages of the SARS-CoV-2 pandemic, when very few treatment options are available. The iminosugar Miglustat is a well-characterized drug for the treatment of rare genetic lysosome storage diseases such as Gaucher and Niemann-Pick type C, and has also been described to be active against a variety of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2c239021-fadb-5af0-9672-5ca9faeeaa32
DOI: 10.1101/2020.05.18.101691

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Repurposing of Miglustat to inhibit the coronavirus Severe Acquired Respiratory Syndrome SARS-CoV-2DOI 10.1101/2020.05.18.101691Read

Drug Repurposing and Lysosomal Storage Disorders: A Trick to Treat.Semantic proximity Read

The Lysosome: A Potential Therapeutic Juncture between the COVID-19 Pandemic and Niemann-Pick Type C DiseaseSemantic proximity Read

Eliglustat tartrate for the treatment of adults with type 1 Gaucher disease.Semantic proximity Read

Repurposing Gaucher disease therapy for Saposin C deficiency: Proof-of-concept with eliglustat.Semantic proximity Read

“Amantadine disrupts lysosomal gene expression; potential therapy for COVID19”Semantic proximity Read

Isofagomine- and 2,5-anhydro-2,5-imino-D-glucitol-based glucocerebrosidase pharmacological chaperones for Gaucher disease intervention.Semantic proximity Read

Discovery of re-purposed drugs that slow SARS-CoV-2 replication in human cellsSemantic proximity Read

The Acid Ceramidase Is a SARS-CoV-2 Host FactorSemantic proximity Read

Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the sigma-1 receptor and autophagySemantic proximity Read

Platycodin D prevents both lysosome- and TMPRSS2-driven SARS-CoV-2 infection <i>in vitro</i> by hindering membrane fusionSemantic proximity Read

The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of beta-glucosidase.Semantic proximity Read

Protein misfolding diseases: Prospects of pharmacological treatment.Semantic proximity Read